Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: June 2024

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

Bettina Hamelin, President (Organization)

Results 1-6 of 6

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance
    Communication date: 2024-06-27
    Posted date: 2024-07-08
    Communication number: 371-609748 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-06-19
    Posted date: 2024-07-08
    Communication number: 371-609747 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Gary Vidal, Member of Parliament | House of Commons

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-06-13
    Posted date: 2024-07-08
    Communication number: 371-609746 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Rosemary Moodie , Senator | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-06-12
    Posted date: 2024-07-08
    Communication number: 371-609745 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Geneviève Lévesque, Senior Parliamentary and Legal Affairs Advisor | Senate of Canada

    Subject Matter of the communication: Consumer Issues, Federal-Provincial Relations, Health, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2024-06-10
    Posted date: 2024-07-08
    Communication number: 371-609743 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Randy Hoback, Member of Parliament | House of Commons

    Subject Matter of the communication: Agriculture, Consumer Issues, Foreign Affairs, Health, International Relations, International Trade, Taxation and Finance, Intellectual Property, Research and Development, Science and Technology
    Communication date: 2024-06-07
    Posted date: 2024-07-08
    Communication number: 371-609739 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: